At the last check on Thursday, Zoetis Inc.’s (NYSE:ZTS) stock was down -$2.6, moving down -1.43 percent to $178.88. The average number of shares traded per day over the past five days has been 1,568,008 shares. 2 times new highs have been achieved over the past 5 days, with a -$3.94 fall in that time frame. In the last twenty days, the average volume was 1,553,697, while in the previous 50 days, it was 1,848,245.
Since last month, ZTS stock retreated -1.62%. Shares of the company fell to $177.65 on 09/21/23, the lowest level in the past month. A 52-week high of $194.99 was reached on 07/27/23 after having rallying from a 52-week low of $124.15. Since the beginning of this year, ZTS’s stock price has risen by 22.06% or $32.25, and marked a new high 21 times. However, the stock has declined by -8.26% since its 52-week high.
ZTS stock investors should be aware that Zoetis Inc. (ZTS) stock had its last reported insider trading activity 3 days ago on Sep 18. Lagano Roxanne, the Executive Vice President of the company, disposed of 923 shares for $179.58 on Sep 18. It resulted in a $165,752 divestment by the insider. Chen Heidi C. sold 9,905 shares at an average price of $180.15 on Sep 15. The insider now owns 27,478 shares following the transaction. On Sep 01, Executive Vice President Lagano Roxanne sold 923 shares at $192.97 apiece. The transaction was valued at $178,111.
Valuation Metrics
Right now, Zoetis Inc. (ZTS) has a P/E ratio of about 37.62. The stock’s beta is 0.78. Besides these, the trailing price-to-sales (P/S) ratio of 10.15, the price-to-book (PB) ratio of 17.87, and the price-to-cash flow ratio of 64.96 may also be considered.
The latest dividend of $0.3750 per share was paid out, remained unchanged from last year’s $0.3750. On Thursday December 8 2022, a $0.05 dividend increase was announced.
Financial Health
In the three months ended June 29, Zoetis Inc.’s quick ratio stood at 2.00, while its current ratio was 3.50, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 1.42, and the total debt-to-equity ratio was 1.42. On the profitability front, the trailing twelve-month gross margin is 70.60% percent. In the year ended June 29, EBITDA margin amounted to 41.99%, whereas operating margins totaled 34.40%. Based on annual data, ZTS earned $5.63 billion in gross profit and brought in $8.08 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 17.20%. Return on equity (ROE) for the past 12 months was 48.70%.
In Zoetis Inc.’s quarter-end financial report for June 29, it reported total debt of $6.55 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. ZTS’s revenue rose 5.87% to $2.0 billion during the quarter, while net income inched up to $2.18 billion. While analysts expected Zoetis Inc. to report $1.31 quarterly earnings, the actual figure was $1.41 per share, beating the consensus estimate by 7.60%. During the quarter, the company generated $1.05 billion in EBITDA. The liabilities of Zoetis Inc. were 9.13 billion at the end of its most recent quarter ended June 29, and its total debt was $6.78 billion. The value of shareholders’ equity is $460.32 million.
Technical Picture
This quick technical analysis looks at Zoetis Inc.’s (ZTS) price momentum. With a historical volatility rate of 20.04%, the RSI 9-day stood at 34.89% on 20 September.
With respect to its five-day moving average, the current Zoetis Inc. price is down by -2.16% percent or -$3.94. At present, ZTS shares trade -2.96% below its 20-day simple moving average and +1.72% percent above its 100-day simple moving average. However, the stock is currently trading approximately +4.04% above its SMA50 and +13.58% above its SMA200.
Stochastic coefficient K was 17.91% and Stochastic coefficient D was 16.81%, while ATR was 3.72. Given the Stochastic reading of 7.32% for the 14-day period, the RSI (14) reading has been calculated as 40.31%. As of today, the MACD Oscillator reading stands at -1.54, while the 14-day reading stands at -3.82.
Analyst Ratings
HSBC Securities launched its rating on Zoetis Inc. (NYSE: ZTS) to a Buy in a note to investors on September 06, 2023. Zoetis Inc. (ZTS) has been rated Buy by analysts. According to 0 brokerage firms, ZTS is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Zoetis Inc. stock as buy, with 13 recommending it as overweight.
With a median target price of $225.00, the current consensus forecast for the stock is $195.00 – $260.00. Based on these forecasts, analysts predict Zoetis Inc. (ZTS) will achieve an average price target of $226.00.
